Coagulopathy and blood component transfusion in trauma

Slides:



Advertisements
Similar presentations
Part 2 Terry Kotrla, MS, MT(ASCP)BB
Advertisements

TREATMENT Coagulopathy of Liver Failure. Fresh Frozen Plasma – Most effective way to correct hemostasis in patients with liver failure – Infusion (5-10mL/kg)
Dr G Ogweno Consultant Anaesthesiologist and Lecturer in Medical Physiology Department of Medical Physiology Kenyatta University Nairobi, Kenya.
Hemostasis-directed resuscitation in trauma
Uncontrolled Hemorrhagic Trauma: When all else fail to stop Mohamed Saleh, MD Department of Anesthesia and Intensive Care, Ain-Shams University.
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Massive transfusion: New Protocol
Transfusion Management of massive haemorrhage in children Ongoing severe bleeding (overt / covert) and received 20ml/kg of red cells or 40ml/kg of any.
Blood Components Dosage And Their Administration
1 5/8/2015 Seven Day Storage At 4°C Of Previously -80°C Frozen AB Plasma Sm. Remco Strelitski, BSc Chief Lab technician, Military Blood Bank, Netherlands.
A/Prof Larry McNicol. Improves the patient’s own blood and avoids unnecessary transfusions. ‘THE THREE PILLARS’ Minimise blood loss Optimise blood volume.
Severe Sepsis Initial recognition and resuscitation
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CNRN, CEN, NP Education Specialist LRM Consulting Nashville, TN.
Massive Transfusion Mary Jo Drew, MD, MHSA Chief Medical Officer Pacific Northwest Blood Services Region.
Blood Clotting Robin Gray.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
Transfusing tiny soldiers Ramsey C. Tate, MD. Applying combat-derived massive transfusion protocols to pediatric trauma patients.
D - DEATH I - IS C - COMING DIC is an important contributor to maternal mortality and morbidity.
Definition of Massive Transfusion Replacement of a blood volume equivalent within 24hr Transfusion>10 unit within 24 hr Transfusion > 4 units in 1 hr.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
1 Disseminated Intravascular Coagulation Paramedic Program Chemeketa Community College.
1 Massive Blood Transfusion Massive transfusion, defined as the replacement by transfusion of more than 50 percent of a patient's blood volume in 12 to.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
A bleeding diathesis has been recognized in pt. with CCHD, a variety of coagulation abnormalities has been postulated: 1- Polycythemia 2- Hyper viscosity.
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Massive blood transfusion
Damage Control Surgery Principles Dr. Josip Janković Dr. Boris Hrečkovski Department of surgery General hospital Slavonski Brod.
Omar Alsuhaibani Transfusion Medicine Journal Club February 2, 2010.
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
Dr Ahmed abdulwahab. Hemorrhage is still one of the leading cause of maternal mortality all over the world DEFINITION Primary post partum hemorrhage.
Fluids and blood products in trauma
Basic Clinician Training Module 2
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
BLOOD TRANSFUSIONS Dr. Tamara Wagenheim.
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Shock and Trauma Resuscitation Bonjo Batoon, CRNA, MS R Adams Cowley Shock Trauma Center Baltimore, MD.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Basic Clinician Training Module 6
Blood component therapy This is the seperation of whole blood into its individual components to optimize individual therapeutic potency based on sound.
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
Intern 謝旻翰. Introduction (I) Benefit –Volume restoration, improved O2 carrying capacity Risk –Transfusion reaction, blood-bore pathogen, limited supply,
Massive Transfusion in Trama By R1 彭育仁. Brief History(1) 26 y/o male came to our ER due to massive bleeding from cutting wound over right neck and left.
Investigation of Haemostasis MS. c. program Lab-9.
Fibrinolysis and Hyperfibrinolysis TEG Analysis
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Coagulopathy in Trauma Seunghwan Kim, M.D. Dept. of Emergency Medicine College of Medicine, Yonsei University.
Chapter 38 Hematologic Disorders and Oncologic Emergencies Unit 8 Multisystem Alterations Seventh Edition Linda D. Urden Kathleen M. Stacy Mary E. Lough.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
بسم الله الرحمن الرحیم COMPLICATIONS of Transfusion Therapy
“Running with the Bulls” Massive Transfusion in the ED
THE TRAUMA INDUCED COAGULOPATHY CLINICAL SCORE: A TOOL FOR SEVERE TRAUMA PATIENTS MANAGEMENT Tonglet M, Minon JM, Vergnion M, CHR de la Citadelle, LIEGE,
Acquired coagulation disorders
Diagnosis and Management of shock
CRASH 2 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2):
Disseminated Intravascular Coagulation
Coagulation Disorders Importance in surgical practice
Drugs Affecting Blood.
Perioperative factor concentrate therapy
Trauma Resuscitations, Past, Present and Future Practices
Blood Components Dosage And Their Administration
Presentation transcript:

Coagulopathy and blood component transfusion in trauma

life-threatening bleeding Trauma 1 in 10 death worldwide uncontrolled bleeding 40% of trauma-related deaths leading cause of potentially preventable and early in-hospital death life-threatening bleeding vascular injury coagulopathy consumption and dilution of coagulation factors and platelets, dysfunction of platelets and the coagulation system, increased fibrinolysis, compromise of the coagulation system by the infusion of colloid, hypocalcemia, and disseminated intravascular coagulation-like syndrome

Pathophysiology of coagulopathy in trauma 2) Consumption coagulopathy precise cause is difficult to identify and multifactorial

Pathophysiology of coagulopathy in trauma 3) Increased fibrinolysis trauma pts. demonstrate both hypofibrinolytic and hyperfibrinolytic states severity of injury, time from injury에 따라 달라 진다 Simmons et al. trauma 직후 : fibrinolytic activity increase mild~moderate inj.: 24h 이후 normal major inj.: remain elevated hypothermia : fibrinolytic activity 증가

Pathophysiology of coagulopathy in trauma 4) Hypothermia-induced coagulopathy significant risk factors for life-threatening coagulopathy injury severity score > 25 systolic BP < 70mmHg acidosis with pH < 7.10 hypothermia with BT < 34℃ lethal triad hypothermia, metabolic acidosis, progressive coagulopathy

Pathophysiology of coagulopathy in trauma 4) Hypothermia-induced coagulopathy effect of hypothermia on coagulopathy is difficult to identify by routine coagulation screening tests (PT, aPTT) hypothermia impairs thrombin generation and the formation of platelet plugs and fibrin clots increase clot lysis results in coagulopathy and uncontrollable bleeding

Pathophysiology of coagulopathy in trauma 5) Decreased levels of coagulation factors and platelets large volumes of crystalloid and colloid thrombocytopenia is seen commonly in pts. received massive blood transfusion platelets are present in whole blood 현재는 RBC unit 사용 negligible amounts of coagulation factors and platelets thrombocytopenia and subnormal levels of coagulation factors often occur at early stage during massive RBC transfusion

Pathophysiology of coagulopathy in trauma 6) The effect of acute RBC loss on coagulation unclear as no data from trauma pts. are available, the effect of acute RBC loss on coagulation is unknown

Effect of massive RBC transfusion on coagulation 과거 수혈은 주로 whole blood에 의존, 현재는 specific component therapy blood component therapy optimizes the use of resources by allowing components to be used in different pts. avoids potentially harmful effects caused by transfusion of surplus constituents whole blood와 비교했을 때 massive RBC transfusion 시 earlier stage에서 coagulopathy 발생 (low levels of platelets and clotting factors)

Effect of massive RBC transfusion on coagulation relationship between volume of blood loss, replacement volume and the reduction in coagulation factor and platelet levels are difficult to establish increased acid load from RBC units may also contribute to coagulopathy pH of an RBC unit is low, and decreases progressively during storage from 7.0 to 6.3 plasma의 high-buffering capacity로 acid-base disturbance는 잘 일어나지 않는다 trauma pts. are already acidotic, massive transfusion of RBCs further increase acid load, exacerbate the ongoing coagulopathy

Unresolved issues regarding blood transfusion in trauma 1) Optimal replacement therapy for FFP and platelets massive RBC transfusion 시 FFP, platelets, fibrinogen concentrate or cryoprecipitate를 같이 줘야한다는 건 알 고 있지만 universal guideline은 없다 based on experts’ opinion or personal experience

Unresolved issues regarding blood transfusion in trauma 1) Optimal replacement therapy for FFP and platelets 1st approach transfuse FFP and plts. prophylactically after a certain number of units of RBCs FFP:RBC → 1:10 ~ 2:3 plt:RBC → 6:10 ~ 12:10 coagulopathy의 발생을 예방하거나 bleeding을 줄인다는 증거는 없다 benefit도 확실하지 않다

Unresolved issues regarding blood transfusion in trauma 1) Optimal replacement therapy for FFP and platelets 2nd approach transfuse FFP, plt, cryoprecipate only when there is clinical or laboratory evidence of coagulopathy microvascular bleeding PT or aPTT > 1.5 times normal value thrombocytopenia < 50000 fibrinogen concentration < 1g/L occult site의 microvascular bleeding은 발견하기 힘들다 lab. test may take 30~60min

Effect of RBC transfusion on longer-term outcome in trauma 1) Multiple organ failure (MOF) RBC transfusion has been to shown to be an independent risk factor for post-injury MOF 513명의 major trauma, severe bleeding and haemorrhagic shock 환자에 대한 연구에서 injury MOF 발생한 환자는 첫 12h 이내에 RBC 13unit 수혈받음 MOF 발생하지 않은 환자는 3.8unit decrease in volume of RBC transfused may decrease the risk and severity of MOF

Effect of RBC transfusion on longer-term outcome in trauma 2) Post-injury infection large amounts of foreign antigens may lead to downregulation of the immune system alternative non-immune-mediated mechanism stored RBCs are less deformable and more rigid, once transfused they may obstruct capillary blood flow, predisposing tissue to ischemia and infection as well as poor delivery of prophylactic antibiotics

The need for haemostatic agents ideal hemostatic agent should be efficacious in a wide range of hemostatic dysfunctions, simple to store and use, and have a rapid action activated recombinant factor Ⅶ (rFⅦa) is a potential candidate effective hemostasis in a wide range of bleeding conditions significantly dcreased RBC transfusion requirement in pts. with major trauma optimal preconditions should be achieved before administration

The need for haemostatic agents optimal preconditions fibrinogen concentration ≥ 0.5g/L platelet count ≥ 50/L pH ≥ 7.2

Conclusions non-surgically correctable bleeding remains a major challenge currently, blood component replacement therapy remains the mainstay of coagulopathy-related bleeding although RBC transfusion can be life-saving, its negative effects on post-injury outcome have been well documented hemostatic agents, which can effectively control bleeding and reduce the amount of RBC required, may decrease mortality and morbidity in trauma pts. but are unlikely to replace blood transfusion completely